Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
about
Research Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's DiseaseThe cell biology of inflammasomes: Mechanisms of inflammasome activation and regulationWhen Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBDPapilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of ApcMin/+ mice.Omics Approaches to Identify Potential Biomarkers of Inflammatory Diseases in the Focal Adhesion Complex.Reparative inflammation takes charge of tissue regeneration.The Hygiene Hypothesis and Its Inconvenient Truths about Helminth InfectionsProtected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury.Intrinsic Defense Mechanisms of the Intestinal EpitheliumTargeting IL-17A attenuates neonatal sepsis mortality induced by IL-18.Autonomous immunity in mucosal epithelial cells: fortifying the barrier against infection.Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer.Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis.MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome.Cytokines IL-17 and IL-22 in the host response to infection.Inflammasomes and Cancer.Microbiota: a key orchestrator of cancer therapy.Hemidesmosome integrity protects the colon against colitis and colorectal cancerEpithelial Histone Deacetylase 3 Instructs Intestinal Immunity by Coordinating Local Lymphocyte Activation.Integrated Stress Response Mediates Epithelial Injury in Mechanical Ventilation.Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages.Inflammasomes in the Gut Mucosal Homeostasis.Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation.Epithelial EZH2 serves as an epigenetic determinant in experimental colitis by inhibiting TNFα-mediated inflammation and apoptosis.Interleukin-18: Biological properties and role in disease pathogenesis.Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.NLRC4 inflammasomopathies.Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18.Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.Toll-like Receptors and Inflammatory Bowel Disease.Inflammatory cell death in intestinal pathologies.Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease.HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation.Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut.IL-18Rα-deficient CD4(+) T cells induce intestinal inflammation in the CD45RB(hi) transfer model of colitis despite impaired innate responsiveness.Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells.
P2860
Q28066444-5E0134EB-8805-4BB5-ABD3-A7200C4D1885Q28079360-3B316072-BB58-400F-859C-EC41156F62F0Q28079656-7B66856D-A499-4788-8785-676E504AABCCQ33571959-DACB784D-05E0-465F-B609-ED1DD608129DQ33631616-37F513D5-4A14-469F-9E47-E0758AF07E92Q35899475-5CCA6CD2-B7AD-4847-85AE-B22B5A68FCD2Q36134464-513D0083-C7CE-4ED5-9F7E-4B3631AD188AQ36282619-4D390063-A9A9-4E51-81BA-132C88B45B15Q36883488-44D74078-8335-4FDB-90CA-9C15E400EDF4Q36905009-C793D3AF-C222-4169-9992-5FF2CB05D85FQ36945471-ECE632C9-275F-41DD-A4BB-92364F1D654AQ37003742-29FBE058-DA8B-4046-8391-16E18E06990CQ37141763-BDDE99D6-08D4-442A-95C1-67B88A0C8BD4Q37327533-C56B2B2D-1E27-42DD-8639-8575D5214236Q38795315-5D8A06F9-646E-44FE-B4EE-E982F01F1771Q39028574-65977483-8F92-4F33-AA72-6AF8AEC51FD4Q39091104-6FB9A747-E43B-4078-A19C-93265B461DF9Q39183428-AA0C0D66-1F32-47D7-9C10-65E081910B55Q39637327-A82A73CA-E24E-42A9-BA33-C649071492CEQ40216623-A0F4DF98-8824-48A3-B38A-913A7877A7BBQ40265162-CB456632-9BC2-49C8-B8CF-DFB9A54A81C4Q41688556-414AE9BF-BA80-4D48-AAA5-6F4C15D0F093Q41935570-5A204BAA-52F2-4C22-A6E4-5DCB9CEC9C92Q42127776-9EEC08B7-051C-49B0-A320-A09883D3E324Q42130297-163A36B8-AF91-40C5-BE33-3872F77C275DQ43058868-DCA3A838-C5EB-4566-87F8-F8197D39D261Q47285927-C02D67B4-E591-483D-98B1-9A7AFA0898E8Q47332836-6928F1E4-9FF2-4860-9DD9-D3D666E8DEADQ47666139-55E939E3-21DE-4CFA-8CAC-A6933AFC3AF5Q47730624-92285C64-DF83-4354-B427-0CAB4B6101CDQ47813664-FC9BA53F-93B1-4956-9540-C1C66729FEDAQ48120325-B1317AC1-0AB6-4F28-8678-CA191036B7CAQ48258109-9A7E3C0D-C287-4F6B-AB26-4CF1012F342FQ49416505-DE6258F0-C3CF-4BBA-8164-F2C057434457Q50062526-C1E48F29-92E9-45E2-B432-7FAF62E80D02Q52613216-96196FC3-33BB-437C-92B3-8FC8AA715EA7Q52690423-42BF2B04-CC4D-4EF7-9197-B7972B7D745EQ52728109-707C9335-4E7C-4B28-8952-FB44177D0E7EQ53125773-CEC8BF4A-60FF-4E24-8409-457C28567106Q55065364-AE8CBFB4-B6AA-46B7-AB6A-820DC4217F73
P2860
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
@nl
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
@ast
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
@en
type
label
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
@nl
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
@ast
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
@en
prefLabel
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
@nl
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
@ast
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
@en
P2093
P2860
P3181
P1433
P1476
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.
@en
P2093
Christian C D Harman
Eran Elinav
Jun Siong Low
Marcel R de Zoete
Morven Graham
Nicola Gagliani
Noah W Palm
Richard A Flavell
Roni Nowarski
Ruaidhrí Jackson
P2860
P304
P3181
P356
10.1016/J.CELL.2015.10.072
P407
P577
2015-12-01T00:00:00Z